Eikon Therapeutics · 1 day ago
Executive Director, Clinical R&D (Translational Medicine and Companion Diagnostics)
Jersey City, NJ
Full-time
Onsite
Director/Executive
$304K/yr - $332K/yr
10+ years expEikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the intersection of chemistry, engineering, computation, and biology to discover novel treatments for life-threatening diseases. As Executive Director of Translational Medicine and Companion Diagnostics, you will lead efforts in bridging preclinical discovery to clinical development, ensuring the integration of companion diagnostics and driving biomarker research strategies.
BiotechnologyHealth CareLife ScienceMedical
Responsibilities
Collaborate with cross-functional teams to develop and implement a comprehensive translational medicine strategy aligned with the company's overall drug development goals
Provide strategic input into preclinical and clinical development plans, ensuring seamless translation of scientific findings
Identify and champion novel translational approaches and technologies to enhance drug development
Establish and maintain strong collaborations with internal research, clinical development, regulatory affairs, and commercial teams
Lead the identification, validation, and implementation of relevant biomarkers (pharmacodynamic, predictive, prognostic) to inform clinical trial design, patient selection, and drug response monitoring
Oversee the development and execution of biomarker plans within clinical protocols
Ensure the rigorous scientific validation and clinical utility of identified biomarkers
Foster partnerships with internal and external experts, harnessing diverse knowledge to advance biomarker research
Drive the incorporation of advanced technology platforms for biomarker discovery, optimizing analysis and assessment
Contribute to the scientific community through publications, presentations, and active engagement in knowledge-sharing
Lead the strategy and execution for the development and regulatory approval of companion diagnostic assays in collaboration with diagnostic partners
Oversee the selection and management of diagnostic development partners
Ensure the timely and successful integration of companion diagnostics into clinical trials and commercialization strategies
Maintain a thorough understanding of relevant regulatory guidelines for companion diagnostics (e.g., FDA, EMA)
Ensure all translational medicine and companion diagnostic activities are conducted in compliance with relevant regulatory guidelines and ethical standards
Contribute to regulatory submissions, including INDs, NDAs/BLAs, and companion diagnostic premarket approvals/supplements
Interact with regulatory agencies on matters related to translational medicine and companion diagnostics
Build, mentor, and lead a high-performing team of translational scientists and companion diagnostic experts
Qualification
Required
MD or DO degree with 10+ years of experience in biomarker research, validation, and interpretation within drug development
Demonstrated experience in leading the development and regulatory approval of companion diagnostic assays
Strong understanding of clinical trial design, statistical principles, and regulatory requirements for drug and diagnostic development
Exceptional analytical and problem-solving skills, capable of uncovering valuable insights from complex data sets
Strategic thinking and problem-solving abilities with a results-oriented approach
Experience building and leading high-performing teams
Ability to thrive in a dynamic, fast-paced, and interdisciplinary biotech environment
Benefits
401k plan with company matching
Medical (premiums covered by Eikon at 95%)
Dental and vision insurance (premiums covered by Eikon at 100%)
Mental health and wellness benefits
Weeklong summer and winter holiday shutdowns
Generous paid time off and holiday policies
Life/AD&D Insurance (premiums covered by Eikon at 100%) and optional supplemental employee-paid life/AD&D policies
Enhanced parental leave benefit
Daily subsidized lunch program when on-site
Company
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
201-500 employees
H1B Sponsorship
Eikon Therapeutics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (17)
2023 (7)
2022 (3)
2021 (1)
Funding
Current Stage
Late StageTotal Funding
$1.12BKey Investors
The Column Group
2025-02-26Series D· $350.7M
2023-06-01Series C· $106M
2022-01-06Series B· $518M
Leadership Team
Roger Perlmutter
Chairman, President, and CEO
Michael Klobuchar
Chief Operating Officer
Recent News
2026-01-19
pharmaphorum
2026-01-14
Company data provided by crunchbase